Skip to main content
S 3588 117th Congress Senate Health Business records Chemical and biological weapons Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Government information and archives Health programs administration and funding Health technology, devices, supplies Infectious and parasitic diseases Manufacturing Medical research Public contracts and procurement Research administration and funding Research and development

Medical Countermeasures Surge Capacity Act of 2022

Introduced: February 7, 2022 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 7, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 7, 2022
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Medical Countermeasures Surge Capacity Act of 2022

This bill expands the scope of research and development activities carried out by the Biomedical Advanced Research and Development Authority (BARDA) to include support for maintaining and improving domestic manufacturing surge capacity and capabilities for vaccines, diagnostics, and other medical countermeasures.

In particular, BARDA must enter into transactions with facilities to ensure that domestic manufacturing surge capacity is available to manufacture medical countermeasures and related products in the event of a public health emergency (e.g., by supporting flexible or advanced manufacturing). The Government Accountability Office must report on these efforts.

In addition, BARDA must address support for domestic manufacturing surge capacity in its strategic plan for countermeasure research, development, and procurement.

The bill also reauthorizes through FY2028 a program through which BARDA may support innovative technologies to assist in medical countermeasure research and development using grants, cooperative agreements, and other transactions.

What's happening now February 7, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • S 3799 Related bill PREVENT Pandemics Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Hassan, Margaret Wood
New Hampshire · Feb 7, 2022
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3588: Medical Countermeasures Surge Capacity Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-S-3588/
MLA
"S. 3588: Medical Countermeasures Surge Capacity Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-3588/.
Bluebook (legal)
S. 3588, 117th Cong. (2026), https://openamerica.io/bill/117-S-3588/.
Markdown link
[S. 3588: Medical Countermeasures Surge Capacity Act of 2022](https://openamerica.io/bill/117-S-3588/)
Report a problem